Class II · ModerateRecall completed
Rifampin Capsules USP
Could cause temporary or reversible harm; serious harm is unlikely.
Does this affect you?
Check your lot numberLot #: A201064, Exp. Date March 2024
Where it was soldNationwide within the United States
Find the lot number printed on your box or bottle. If it matches — and you take this medicine — call your pharmacist. Don't stop a prescribed medicine on your own.
What happened
Subpotent Drug
What to do
- Check the lot number and expiry on your medicine against the recall above.
- Talk to your pharmacist or doctor before changing anything — don't stop on your own.
- Report any problems to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
Who makes it
Made byLupin Limited Aurangabad 431 210 India foreign manufacturer
| Distributed by / for | Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 |
| NDC | 6818-0659-06 |
Show the full FDA record
| Full product label | Rifampin Capsules USP, 300mg, 30-count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, Manufactured by: Lupin Limited Aurangabad 431 210 India, NDC 6818-0659-06 |
| Recalling firm | Lupin Pharmaceuticals Inc. |
| Distribution | Nationwide within the United States |
| Quantity | 26,352 bottles |
| Recall initiated | 2024-03-21 |
| Report date | 2024-04-17 |
| Recall completed | 2025-04-04 |
| Recall number | D-0437-2024 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Baltimore MD United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗
This is public FDA recall information, not medical advice. A recall does not always mean your specific bottle is affected. Never stop a prescribed medicine without asking your pharmacist or doctor.